NCT07306962

Brief Summary

Reconstruction of segmental mandibular defects is in a continuous state of evolution utilizing the recent advances in Computer-Aided Designing (CAD) and preoperative Virtual Surgical Planning (VSP). The anterior iliac crest is one of the ideal reservoirs for autogenous harvesting of a bi-cortical bone block with 1:1 cortical to cancellous bone ratio which is optimal for rapid and predictable consolidation. The aim of this study is the utility of VSP guided by CT and confirmation by histopathological analysis in achieving negative margins and preventing recurrence of mandibular ameloblastoma.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
8mo left

Started Jan 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress67%
Jan 2025Jan 2027

Study Start

First participant enrolled

January 1, 2025

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

December 13, 2025

Completed
16 days until next milestone

First Posted

Study publicly available on registry

December 29, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

December 29, 2025

Status Verified

December 1, 2025

Enrollment Period

1.9 years

First QC Date

December 13, 2025

Last Update Submit

December 13, 2025

Conditions

Keywords

segmental mandibular defectanterior iliac crestvirtual surgical planning accuracy

Outcome Measures

Primary Outcomes (1)

  • Histological analysis and degree of lesion invasion determination

    The specimen with the the mounted Safety Margin Calibration Guide will be sent for histological evaluation. For light microscopic examination, the specimens will be embedded in paraffin wax blocks after being fixed in 10% formalin, neutrally buffered, cleaned, and dehydrated using increasing ethanol concentrations. Tissue sections will be cut to a thickness of 4 μm, and stained with hematoxylin and eosin to be examined under a light microscope. The specimen will be cut, using the S35 (0.254-mm thickness) microtome blade, at the preoperatively determined margins according to the virtual lesion segmentation from the proximal and distal sides of the lesion. Since the study is limited to segmental mandibular resection, the full lower border of the mandible was resected and their will be no need for assessment of either coronal or apical margins

    1 month

Secondary Outcomes (1)

  • Postoperative resection margin accuracy analysis

    1 week

Study Arms (1)

Virtual lesion segmentation for mandibular ameloblastoma

EXPERIMENTAL

Patient with mandibular ameloblastoma managed with virtual surgical planning \& Virtual lesion segmentation for the determination of a radiographic 10-mm safety margin.

Device: Virtual lesion segmentation for mandibular ameloblastoma

Interventions

Patient with mandibular ameloblastoma managed with virtual surgical planning \& Virtual lesion segmentation for the determination of a radiographic 10-mm safety margin.

Virtual lesion segmentation for mandibular ameloblastoma

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with histologically confirmed ameloblastoma using a preoperative biopsy.
  • Patients with ameloblastoma that require segmental mandibular continuity defect, not involving the condyle.

You may not qualify if:

  • Patients with lateral segmental mandibular defect involving the condyle.
  • Patients with an active infection at the site of resection.
  • Patients with recurrent lesion after resection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry, Alexandria University

Alexandria, Alexandria Governorate, 21523, Egypt

RECRUITING

MeSH Terms

Conditions

Ameloblastoma

Condition Hierarchy (Ancestors)

Odontogenic TumorsNeoplasms by Histologic TypeNeoplasms

Study Officials

  • yehia A El-Mahallawy, PhD

    Faculty of Dentistry, Alexandria University, Alexandria, Alexandria

    PRINCIPAL INVESTIGATOR

Central Study Contacts

yehia A El-Mahallawy., PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 13, 2025

First Posted

December 29, 2025

Study Start

January 1, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

January 1, 2027

Last Updated

December 29, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

All data will be de-identified to protect the participant data. patients signed an informed consent for the use of their medical records and data for study.

Locations